No breast?
No problem. This data review of prospective trials spanning back to the 1997 reporting of the British Columbia trial points to hypofractionation over 3-4 weeks being a safe and effective treatment option for post-mastectomy radiation that, just as has been the case in the UK for years, may soon become the new standard in the US. | Sayan, Adv Radiat Oncol 2021
The method of execution is really impressive of writers of this blog. This team does really work hard and brings new information to its readers. I am connected with this blog very long and I am really thankful kubet lua dao
ReplyDelete